ATE264684T1 - Antibiotische azalid-zusammensetzungen - Google Patents

Antibiotische azalid-zusammensetzungen

Info

Publication number
ATE264684T1
ATE264684T1 AT02253796T AT02253796T ATE264684T1 AT E264684 T1 ATE264684 T1 AT E264684T1 AT 02253796 T AT02253796 T AT 02253796T AT 02253796 T AT02253796 T AT 02253796T AT E264684 T1 ATE264684 T1 AT E264684T1
Authority
AT
Austria
Prior art keywords
antibiotic
compositions
azalide
azalide compositions
acids
Prior art date
Application number
AT02253796T
Other languages
English (en)
Inventor
Wayne A Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE264684T1 publication Critical patent/ATE264684T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02253796T 2001-05-31 2002-05-30 Antibiotische azalid-zusammensetzungen ATE264684T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29467701P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
ATE264684T1 true ATE264684T1 (de) 2004-05-15

Family

ID=23134451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02253796T ATE264684T1 (de) 2001-05-31 2002-05-30 Antibiotische azalid-zusammensetzungen

Country Status (12)

Country Link
US (1) US20030092640A1 (de)
EP (1) EP1262186B1 (de)
JP (1) JP2003040782A (de)
AT (1) ATE264684T1 (de)
BR (1) BR0201973A (de)
CA (1) CA2387821A1 (de)
DE (1) DE60200391T2 (de)
DK (1) DK1262186T3 (de)
ES (1) ES2218509T3 (de)
MX (1) MXPA02005381A (de)
PT (1) PT1262186E (de)
TR (1) TR200400954T4 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
JP2007277095A (ja) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd アジスロマイシン含有可逆性熱ゲル化水性組成物
WO2007112616A1 (fr) * 2006-04-04 2007-10-11 Union Plastic (Hangzhou) Machinery Co., Ltd. Procédé de commande d'une machine hydraulique pour économiser de l'énergie ou améliorer l'efficacité
EP2098219A1 (de) 2008-03-05 2009-09-09 PARI Pharma GmbH Makrolidzusammensetzungen mit verbessertem Geschmack und verbesserter Stabilität
WO2011104557A1 (en) * 2010-02-24 2011-09-01 Arecor Limited Protein formulations
CN103965273B (zh) 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103690560B (zh) * 2013-12-17 2016-08-17 辽宁海思科制药有限公司 一种转化糖电解质注射液药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
MXPA02007305A (es) * 2000-01-27 2002-11-29 Pfizer Prod Inc Composiciones antiboticas de azalida.
PL359861A1 (en) * 2000-04-27 2004-09-06 Pfizer Products Inc. The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals

Also Published As

Publication number Publication date
JP2003040782A (ja) 2003-02-13
CA2387821A1 (en) 2002-11-30
DE60200391D1 (de) 2004-05-27
ES2218509T3 (es) 2004-11-16
DK1262186T3 (da) 2004-07-26
EP1262186A1 (de) 2002-12-04
BR0201973A (pt) 2003-04-22
US20030092640A1 (en) 2003-05-15
TR200400954T4 (tr) 2004-07-21
EP1262186B1 (de) 2004-04-21
DE60200391T2 (de) 2005-05-04
MXPA02005381A (es) 2002-12-09
PT1262186E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
NO993996L (no) N-heterosykliske derivater som NOS-inhibitorer
CA2398485A1 (en) Azalide antibiotic compositions
CY1108456T1 (el) Ενωσεις βενζιμιδαζολονης
NO20020925D0 (no) N-heterosykliske derivater som NOS-inhibitorer
CY1107896T1 (el) Παρασκευη λυοφιλιωμενης παντοπραζολης και ενεση παντοπραζολης
CY1108707T1 (el) Αναλογα νοσισεπτινης
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
DK1392714T3 (da) Steroider som agonister for FXR
EA199900373A2 (ru) Фармацевтические композиции
BR0206155B1 (pt) composiÇÕes copolimÉricas cristalinas de propileno tendo propriedades àpticas e de selagem aperfeiÇoadas e solubilidade reduzida.
DK1385515T3 (da) Spiropyrazole forbindelser
CY1107331T1 (el) Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης
IT1317716B1 (it) Processo per la preparazione di perfluoropoliossialchileni conterminali ossidrilici.
ATE264684T1 (de) Antibiotische azalid-zusammensetzungen
DK1434779T3 (da) Tværbundne glycopeptid-cephalosporinantibiotika
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
CY1105345T1 (el) Φαινυλαλκινια
ECSP034598A (es) Compuesto lactamico
DK1192139T3 (da) Fremstilling af quinolinsubstituerede carbonat- og carbamatderivater
ATE315380T1 (de) Epothilon zusammensetzungen
IT1317031B1 (it) Procedimento migliorato per la preparazione di (e,z)3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
WO2003011266A3 (en) Azalide antibiotic compositions
NO20014755D0 (no) C(7)-karbonatsubstituerte taksaner som antitumormidler
PT1339703E (pt) Processo para a preparacao de paclitaxel
WO2000040589A3 (en) Novel derivatives from the class of oleandomycin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1262186

Country of ref document: EP

REN Ceased due to non-payment of the annual fee